---
document_datetime: 2023-09-21 19:51:24
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ajovy-epar-all-authorised-presentations_en.pdf
document_name: ajovy-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9694676
conversion_datetime: 2025-12-19 02:39:19.295681
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging                           | Content (concentration)   | Pack size             |
|------------------|-------------------|------------|------------------------|---------------------------|-----------------------------------------------|---------------------------|-----------------------|
| EU/1/19/1358/001 | AJOVY             | 225 mg     | Solution for injection | Subcutaneous use          | Pre-filled syringe (glass)                    | 1.5 mL (150 mg/mL)        | 1 pre-filled syringe  |
| EU/1/19/1358/002 | AJOVY             | 225 mg     | Solution for injection | Subcutaneous use          | Pre-filled syringe (glass)                    | 1.5 mL (150 mg/mL)        | 3 pre-filled syringes |
| EU/1/19/1358/003 | AJOVY             | 225 mg     | Solution for injection | Subcutaneous use          | -filled syringe (glass) in pre- filled pen    | 1.5 mL (150 mg/mL)        | 1 pre-filled pen      |
| EU/1/19/1358/004 | AJOVY             | 225 mg     | Solution for injection | Subcutaneous use          | Pre-filled syringe (glass) in pre- filled pen | 1.5 mL (150 mg/mL)        | 3 pre-filled pens     |

1